Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study

doi:10.4254/wjh.v8.i36.1623

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8210)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

314

WORD

172

HTML

2492

Figures (1-1)

168

Tables (1-1)

155

Sum=3301

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

552

Download

1146

Sum=1698

Publishing Process of This Article

Item

Count

Browse

1371

Download

1840

Sum=3211

Dec 28, 2016 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Dec 28, 2016; 8(36): 1623-1628
Published online Dec 28, 2016. doi: 10.4254/wjh.v8.i36.1623

Open in New Tab Full Size Figure Download Figure

Figure 1 Screening algorithm to detect Didanosine related liver disease in human immunodeficiency virus positive patients previously exposed to Didanosine for > 6 mo. ¹ALT > upper limit normal (ULN) or platelets < lower limit normal (LLN) or TE > 7.65 kPa; ²ALT < ULN and platelets > LLN and TE < 7.65 kPa. TE: Transient elastography; HIV: Human immunodeficiency virus; DDI: Didanosine; ALT: Alanine transaminase; HBV: Hepatitis B virus; HCV: Hepatitis C virus; IQR: Interquartile range.

Citation: Logan S, Rodger A, Maynard-Smith L, O’Beirne J, Fernandez T, Ferro F, Smith C, Bhagani S. Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study. World J Hepatol 2016; 8(36): 1623-1628
URL: https://www.wjgnet.com/1948-5182/full/v8/i36/1623.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i36.1623